BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38014454)

  • 1. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer.
    Sunaga N; Kaira K; Shimizu K; Tanaka I; Miura Y; Nakazawa S; Ohtaki Y; Kawabata-Iwakawa R; Sato M; Girard L; Minna JD; Hisada T
    Thorac Cancer; 2024 Jan; 15(2):131-141. PubMed ID: 38014454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
    Feng Q; Li S; Ma HM; Yang WT; Zheng PS
    Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1.
    Liao Y; Feng J; Sun W; Wu C; Li J; Jing T; Liang Y; Qian Y; Liu W; Wang H
    J Exp Clin Cancer Res; 2021 Aug; 40(1):275. PubMed ID: 34465343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway.
    Fang Z; Zhong M; Zhou L; Le Y; Wang H; Fang Z
    Bioengineered; 2022 Mar; 13(3):6807-6818. PubMed ID: 35246020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR6 promotes osteogenesis by activating the Wnt/β-catenin signaling pathway.
    Liu SL; Zhou YM; Tang DB; Zhou N; Zheng WW; Tang ZH; Duan CW; Zheng L; Chen J
    Biochem Biophys Res Commun; 2019 Oct; 519(1):1-7. PubMed ID: 31500806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
    Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
    Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling.
    Mei Y; Liu YB; Cao S; Tian ZW; Zhou HH
    Cell Death Dis; 2018 Sep; 9(10):942. PubMed ID: 30237512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor.
    Gong X; Carmon KS; Lin Q; Thomas A; Yi J; Liu Q
    PLoS One; 2012; 7(5):e37137. PubMed ID: 22615920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer.
    Yu JE; Ju JA; Musacchio N; Mathias TJ; Vitolo MI
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP1 facilitates non-small cell lung cancer progression by regulating the KIF2A-mediated Wnt/β-catenin pathway.
    Sun M; Wang L; Ge L; Xu D; Zhang R
    Funct Integr Genomics; 2023 Dec; 24(1):4. PubMed ID: 38102458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
    Shu X; Chen M; Liu SY; Yu L; Sun LX; Sun LC; Ran YL
    Cancer Med; 2023 Feb; 12(4):4510-4520. PubMed ID: 36047666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
    Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
    Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.
    Wang R; Liu J; Li K; Yang G; Chen S; Wu J; Xie X; Ren H; Pang Y
    J Exp Clin Cancer Res; 2021 Oct; 40(1):318. PubMed ID: 34645486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.